Zaki Djemal

Unibeam offers a secure and easy way for companies to verify customers using their phones SIM card. It protects against hacks like SIM swaps and social engineering by linking your phone’s SIM with your mobile device. No need to download any apps—Unibeam works on any device and network, combining the ease of OTP (One-Time Password) with the extra protection of SIM-based security. Trusted by millions worldwide, Unibeam helps with safe logins, approving transactions, and more. For more information, please visit www.unibeam.com.

Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.

Insignito is a global leader in drone acoustics technologies. Our proprietary acoustic engine enables both civilian and defense customers to reduce noise, detect drones, and optimize mission performance. Our flagship product is Acoustic Drone Detection — a low-cost, high-performance acoustic drone detector with exceptional range and adaptability. Our additional products include: Silent Propellers – we design quiet propellers that significantly reduce drone noise, without compromising aerodynamic efficiency Acoustic Mission Planning – a mission planner that conserves battery life and minimizes signature exposure across acoustic, thermal, and SIGINT signatures Founded by veterans of an elite IDF unit, Insignito combines deep technical expertise with operational insight. Our solutions are dual-use and already deployed in collaborations with leading defense partners.

Starling produces the Pathfinder fixed wing eVTOL Pathfinder

Lembas is an AI-powered bioactive discovery company pioneering the next generation of science-backed ingredients for functional foods and supplements. Our first solution GLP-1 Edge™, is a natural peptide that supports appetite regulation and metabolic health by enhancing the body’s own GLP-1 response. GLP-1 Edge™ is food-grade, clinically validated, and easy to integrate into everyday products like bars, shakes, snacks, gummies, and supplements. It works with the body, not against it, making it an ideal companion for consumers looking to manage their weight naturally, safely, and sustainably. At the core of Lembas is a proprietary AI platform that accelerates the discovery and design of targeted bioactive peptides. Backed by patent-pending university technology, Lembas is unlocking new bioactive ingredients across a broader range of health and wellbeing benefits. This is just the beginning. Stay tuned. Founded in 2024, Lembas is backed by leading investors including Flora Ventures, Bluestein, Fresh Fund, Longevity Venture Partners, Maia Ventures, Siddhi Capital, Mandi Ventures, and SDH. Our team brings deep expertise in biotech, nutrition, AI, and consumer health, with leadership experience from companies like Mondelez, PepsiCo, IFF, Brightseed, and Shiru. Backed by science. Designed for real life.

Chamelio is the Legal Intelligence Platform built for modern in-house legal teams. Instead of relying on generic AI or static CLM workflows, Chamelio learns directly from each organization’s own contracts, historical negotiations, templates, and legal decisions, transforming that institutional knowledge into actionable intelligence. Legal teams use Chamelio to negotiate faster, stay consistent, and eliminate repetitive manual work through agentic workflows that operate on their behalf. From AI-driven redlining to approvals orchestration to intelligent Q and A over legal knowledge, Chamelio helps legal become a proactive enabler, not a bottleneck. Our platform integrates seamlessly with Slack, Microsoft Teams, Salesforce, Word, and other enterprise tools, meeting legal professionals where work actually happens and weaving AI into existing processes rather than forcing operational overhaul. We partner with high-growth companies and large enterprises alike, helping legal departments reduce turnaround time, protect compliance, accelerate revenue cycles, and expand their impact across the business.

Tenna is redefining electromagnetic spectrum management with cutting-edge RF Spectrum Intelligence solutions for defense and critical mobility sectors. Our software platform enables real-time monitoring, classification, and geolocation of radio-frequency interferences, enabling operations to proactively mitigate interference risks and ensure seamless wireless connectivity. Backed by over 15 years of expertise in electromagnetic warfare, Tenna leads advancements in radiofrequency interference (RFI) detection and mitigation. We are committed to securing the world’s most critical systems and empowering defense and aerospace operations to maintain operational resilience and achieve spectrum dominance.

Kimba’s technology uses AI to analyze biometric data and offer a personalized scent therapy to improve sleep and health.

We build infrastructure for autonomous businesses. Our AI agent systems handle marketing, content, and growth operations end-to-end, so teams can focus on strategy instead of execution.

Swan is redefining the boundaries of modern business efficiency. Were conducting a bold experiment: scaling to $10M ARR per employee with AI agents and a hyper lean team - Product, Software, and Growth. What makes this possible? Weve built the future we believe in. An AI GTM Engineer that turns any GTM process into an agentic workflow in seconds, from prompt to pipeline.

Remepy is Pioneering Hybrid Drugs™. Many medical conditions are better treated by combining pharmaceutical and non-pharmaceutical treatments. Hybrid drugs are a new type of drug asset, that combines traditional drugs with proprietary treatment protocols delivered measured and adapted using our AI capabilities. Remepy’s Digital Molecules™ are designed to be the software apps within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug and are constantly measured and tracked and personalized using advanced AI capabilities. The Digital Molecules™ enhance brain functions that balance the patients neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. We also address physical, motor, psychological, and behavioral symptoms Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.

Restoring the global CO₂ balance by developing a unique marine carbon removal method that delivers optimum scale and quality at an affordable price.

Firmus establishes clarity, tackling the unknowns in every construction project. Applying proprietary AI algorithms, Firmus analyzes PDF drawing sets, identifies design-related risks, and enhances pre-construction decision-making. With Firmus, pre-construction teams mitigate risks early, bid more accurately, and protect their companys reputation. Firmus’ innovative approach to the increasing demand for plan review solutions, allows customers to save significant time and create efficiency, resulting in more projects bid and won, and better relationships between all stakeholders.

InCredi aims to change, simplify, and optimize the way Middle market and SME’s credit is deployed, underwritten, and monitored over time. InCredi provides credit facilitators and companies the potential to thrive through inclusive growth by enabling clarity and complete transparency through a Rapid & Automated platform.

We believe justice should be accessible to all. Our unique approach to civil claims helped resolve thousands of cases with minimum costs and maximum results. We are hiring! Reach out via DM

Unibeam offers a secure and easy way for companies to verify customers using their phones SIM card. It protects against hacks like SIM swaps and social engineering by linking your phone’s SIM with your mobile device. No need to download any apps—Unibeam works on any device and network, combining the ease of OTP (One-Time Password) with the extra protection of SIM-based security. Trusted by millions worldwide, Unibeam helps with safe logins, approving transactions, and more. For more information, please visit www.unibeam.com.

Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.

Insignito is a global leader in drone acoustics technologies. Our proprietary acoustic engine enables both civilian and defense customers to reduce noise, detect drones, and optimize mission performance. Our flagship product is Acoustic Drone Detection — a low-cost, high-performance acoustic drone detector with exceptional range and adaptability. Our additional products include: Silent Propellers – we design quiet propellers that significantly reduce drone noise, without compromising aerodynamic efficiency Acoustic Mission Planning – a mission planner that conserves battery life and minimizes signature exposure across acoustic, thermal, and SIGINT signatures Founded by veterans of an elite IDF unit, Insignito combines deep technical expertise with operational insight. Our solutions are dual-use and already deployed in collaborations with leading defense partners.

Starling produces the Pathfinder fixed wing eVTOL Pathfinder

Lembas is an AI-powered bioactive discovery company pioneering the next generation of science-backed ingredients for functional foods and supplements. Our first solution GLP-1 Edge™, is a natural peptide that supports appetite regulation and metabolic health by enhancing the body’s own GLP-1 response. GLP-1 Edge™ is food-grade, clinically validated, and easy to integrate into everyday products like bars, shakes, snacks, gummies, and supplements. It works with the body, not against it, making it an ideal companion for consumers looking to manage their weight naturally, safely, and sustainably. At the core of Lembas is a proprietary AI platform that accelerates the discovery and design of targeted bioactive peptides. Backed by patent-pending university technology, Lembas is unlocking new bioactive ingredients across a broader range of health and wellbeing benefits. This is just the beginning. Stay tuned. Founded in 2024, Lembas is backed by leading investors including Flora Ventures, Bluestein, Fresh Fund, Longevity Venture Partners, Maia Ventures, Siddhi Capital, Mandi Ventures, and SDH. Our team brings deep expertise in biotech, nutrition, AI, and consumer health, with leadership experience from companies like Mondelez, PepsiCo, IFF, Brightseed, and Shiru. Backed by science. Designed for real life.